Study to Determine the Safety and Efficacy of rFIXFc in Previously Untreated Males With Severe Hemophilia B
Clinical trial NCT02234310 · COMPLETED
Trial details
- NCT number
- NCT02234310
- Sponsor
- Bioverativ, a Sanofi company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-13
- Primary completion
- 2019-08-20
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.